CAJ | 학술논문

目的：分析我国实行传染病网络直报系统后病毒性肝炎年死亡数（率）变化过程及发展趋势，为防控策略提供科学依据。方法采用描述性流行病学、移动平均等方法对我国政府部门1992-2013年期间公开发布的法定传染病报告进行统计分析。重点对近10年来我国病毒性肝炎的年死亡数（率）的变化过程及发展趋势进行研究。对数据进行描述性统计、移动平均等方法进行分析。结果病毒性肝炎年死亡数（率）呈下降趋势，其中乙型肝炎年死亡数（率）小幅度下降，仍占病毒性肝炎死亡数的70％以上；丙型肝炎死亡数（率）从2007年起呈小幅度下降趋势；甲型肝炎和未分型肝炎死亡数（率）呈不同程度的下降；戊型肝炎的死亡数（率）稳定在相对较低水平。结论我国治疗病毒性肝炎的水平在逐步提升，社会对病毒性肝炎的认知逐步提高，但是未来病毒性肝炎特别是乙型肝炎和丙型肝炎的防治依然是有关部门值得高度关注的问题。
목적：분석아국실행전염병망락직보계통후병독성간염년사망수（솔）변화과정급발전추세，위방공책략제공과학의거。방법채용묘술성류행병학、이동평균등방법대아국정부부문1992-2013년기간공개발포적법정전염병보고진행통계분석。중점대근10년래아국병독성간염적년사망수（솔）적변화과정급발전추세진행연구。대수거진행묘술성통계、이동평균등방법진행분석。결과병독성간염년사망수（솔）정하강추세，기중을형간염년사망수（솔）소폭도하강，잉점병독성간염사망수적70％이상；병형간염사망수（솔）종2007년기정소폭도하강추세；갑형간염화미분형간염사망수（솔）정불동정도적하강；무형간염적사망수（솔）은정재상대교저수평。결론아국치료병독성간염적수평재축보제승，사회대병독성간염적인지축보제고，단시미래병독성간염특별시을형간염화병형간염적방치의연시유관부문치득고도관주적문제。
Objective To analyze the changing process and development trend of deaths (mortality)in patients with viral hepatitis after the use of the Internet-based National Notifiable Infectious Disease Reporting System.Methods Descriptive statistical and moving average methods were employed to analyze the infectious disease reports released by the Chinese government during 1992-2013,and the changing process and development trend of deaths (mortality)in patients with viral hepatitis in China over the past 10 years were investigated.Re-sults The annual deaths (mortality)in patients with viral hepatitis showed a decreasing trend.The deaths (mortality)from hepatitis B showed a slight declining trend,accounting for a great proportion (over 70%)of the deaths (mortality)from viral hepatitis;the deaths (mortality)from hepatitis C had shown a slight downward trend since 2007;the deaths (mortality)from hepatitis A and unclassified hepati-tis decreased to different extents;the deaths (mortality)from hepatitis E remained at a relatively low level.Conclusion The treatment of viral hepatitis has been gradually improved in China and the public awareness of viral hepatitis keeps increasing.However,much attention still needs to be given to the prevention and treatment of viral hepatitis,especially hepatitis B and C,by the government.